BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26153108)

  • 1. Development of a cell-based qualitative assay for detection of neutralizing anti-human interleukin-1 receptor antagonist (hIL-1Ra) antibodies in rats.
    Gao J; Li J; Yang M; Wu M; Tu P; Yu Y; Han W
    Immunopharmacol Immunotoxicol; 2015; 37(4):335-42. PubMed ID: 26153108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of anti-erythropoietin antibodies in human serum and plasma: part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies.
    Kelley M; Cooper C; Matticoli A; Greway A
    J Immunol Methods; 2005 May; 300(1-2):179-91. PubMed ID: 15927197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
    Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
    Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
    Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
    J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
    Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
    Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist.
    Simón C; Frances A; Piquette GN; el Danasouri I; Zurawski G; Dang W; Polan ML
    Endocrinology; 1994 Feb; 134(2):521-8. PubMed ID: 8299552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.
    Welsh N; Bendtzen K; Welsh M
    J Clin Invest; 1995 Apr; 95(4):1717-22. PubMed ID: 7706480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice.
    Yoshimura K; Hirsch E
    J Soc Gynecol Investig; 2005 Oct; 12(7):533-8. PubMed ID: 16202930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interleukin-1(IL-1) alpha, beta, IL-1 receptor (IL-1R), IL-1 receptor antagonist (IL-1ra)].
    Hayashi H; Onozaki K
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():62-6. PubMed ID: 20960750
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury.
    Sanderson KL; Raghupathi R; Saatman KE; Martin D; Miller G; McIntosh TK
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1118-25. PubMed ID: 10532636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistics of assay validation in high throughput cell imaging of nuclear factor kappaB nuclear translocation.
    Morelock MM; Hunter EA; Moran TJ; Heynen S; Laris C; Thieleking M; Akong M; Mikic I; Callaway S; DeLeon RP; Goodacre A; Zacharias D; Price JH
    Assay Drug Dev Technol; 2005 Oct; 3(5):483-99. PubMed ID: 16305306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
    Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
    J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
    Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
    J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy.
    Pennucci J; Swanson S; Kaliyaperumal A; Gupta S
    J Biomol Screen; 2010 Jul; 15(6):644-52. PubMed ID: 20508254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.